Thetis Pharmaceuticals to Present at the World Orphan Drug Congress on TP-252, an Investigational Drug for Familial Adenomatous Polyposis Biotech Investing
New Analyses of the Phase 3 POISE Trial of Ocaliva™ (Obeticholic Acid) for the Treatment of PBC Presented at EASL Biotech Investing
Naturally Splendid Revises 2016 First Quarter Gross Sales Figures and Attends International Tradeshow in Singapore Biotech Investing
Orgenesis Approved for Additional European Grant for Further Development of its Type 1 Diabetes Program Biotech Investing
TG Therapeutics, Inc. Announces Issuance of Composition of Matter Patent for TG-1101 in the United States Biotech Investing
vTv Therapeutics Announces Presentations on its Diabetes Product Candidates TTP273 and TTP399 at the Keystone Symposia on New Therapeutics for Diabetes and Obesity Biotech Investing
BriaCell Files a Patent Application to Protect Additional Cancer Vaccines With Genetic Features Thought to Promote Strong Anti-Tumor Activity Biotech Investing
Tolero Pharmaceuticals to Present Updates on Clinical and Preclinical Programs at the AACR Annual Meeting 2016 Biotech Investing
Biogen Data at 2016 AAN Annual Meeting Highlight Its Expansive Portfolio of MS Therapies That Meets Diverse Needs of Patients Biotech Investing
